Accumulating evidences indicate that induction of HO-1 expression act as an endogenous defensive mechanism to reduce tissue injury in the intestinal tract associated with chronic inflammatory conditions (i.e. Inflammatory bowel disease/IBD), including Crohn’s disease (CD) and Ulcerative Colitis (UC) (95). Here, HMOX1 is linked to inflammatory bowel disease.